Cargando…
Comparison of SARS-CoV-2 variant lethality in human angiotensin-converting enzyme 2 transgenic mice
This study compared the lethality of severe acute respiratory syndrome coronavirus 2 variants belonging to the S, V, L, G, GH, and GR clades using K18-human angiotensin-converting enzyme 2 heterozygous mice. To estimate the 50% lethal dose (LD(50)) of each variant, increasing viral loads (10(0)–10(4...
Autores principales: | Lee, Tae-Young, Lee, Hansaem, Kim, Nayoung, Jeon, Pyeonghwa, Kim, Jun-Won, Lim, Hee-Young, Yang, Jeong-Sun, Kim, Kyung-Chang, Lee, Joo-Yeon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437746/ https://www.ncbi.nlm.nih.gov/pubmed/34530046 http://dx.doi.org/10.1016/j.virusres.2021.198563 |
Ejemplares similares
-
J2N-k hamster model simulates severe infection caused by severe acute respiratory syndrome coronavirus 2 in patients with cardiovascular diseases
por: Lee, Hansaem, et al.
Publicado: (2022) -
Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice
por: Oladunni, Fatai S., et al.
Publicado: (2020) -
COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice
por: Lutz, Cathleen, et al.
Publicado: (2020) -
Comparing the Immunogenicity and Protective Effects of Three MERS-CoV Inactivation Methods in Mice
por: Kim, Nayoung, et al.
Publicado: (2022) -
Influence of renin‐angiotensin‐aldosterone system inhibitors on plasma levels of angiotensin‐converting enzyme 2
por: Zimmermann, Tobias, et al.
Publicado: (2021)